Skip to main content

CORRECTION article

Front. Microbiol., 25 February 2022
Sec. Antimicrobials, Resistance and Chemotherapy
Volume 13 - 2022 | https://doi.org/10.3389/fmicb.2022.844615

Corrigendum: Drug Repurposing for the Treatment of Bacterial and Fungal Infections

This article is a correction to:

  1. Drug Repurposing for the Treatment of Bacterial and Fungal Infections

    1. Read original article
\nAndrea Mir-Canturri&#x;Andrea Miró-Canturri†Rafael Ayerbe-Algaba&#x;Rafael Ayerbe-Algaba†Younes Smani Younes Smani*
  • Clinical Unit of Infectious Diseases, Microbiology and Preventive Medicine, Institute of Biomedicine of Seville (IBiS), University Hospital Virgen del Rocío, CSIC, University of Seville, Seville, Spain

A Corrigendum on
Drug Repurposing for the Treatment of Bacterial and Fungal Infections

by Miró-Canturri, A., Ayerbe-Algaba, R., and Smani, Y. (2019). Front. Microbiol. 10:41. doi: 10.3389/fmicb.2019.00041

There is an error in the Funding statement. The funder details for Grant No. PI16/01378 were incomplete. The corrected Funding statement appears below:

“This study was supported by Miguel Servet Tipo I Project grant, Instituto de Salud Carlos III, Subdirección General de Redes y Centros de Investigación Cooperativa, Ministerio de Economía, Industria y Competitividad (CP15/00132), the Instituto de Salud Carlos III, Proyectos de Investigación en Salud (Grant No. PI16/01378)—cofinanced by the European Development Regional Fund A way to achieve Europe, operative program Intelligent Growth 2014-2020. YS is supported by the Subprograma Miguel Servet Tipo I from the Ministerio de Economía y Competitividad of Spain (CP15/00132).”

The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.

Publisher's Note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.

Keywords: repurposing drug, bacteria, fungi, antimicrobial resistance, infection

Citation: Miró-Canturri A, Ayerbe-Algaba R and Smani Y (2022) Corrigendum: Drug Repurposing for the Treatment of Bacterial and Fungal Infections. Front. Microbiol. 13:844615. doi: 10.3389/fmicb.2022.844615

Received: 28 December 2021; Accepted: 31 January 2022;
Published: 25 February 2022.

Edited and reviewed by: Rustam Aminov, University of Aberdeen, United Kingdom

Copyright © 2022 Miró-Canturri, Ayerbe-Algaba and Smani. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

*Correspondence: Younes Smani, eXNtYW5pLWliaXMmI3gwMDA0MDt1cy5lcw==; eV9zbWFuaSYjeDAwMDQwO2hvdG1haWwuY29t

†These authors have contributed equally to this work

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.